AbbVie
ABBV
#29
Rank
$327.31 B
Marketcap
$185.30
Share price
-0.10%
Change (1 day)
8.75%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Number of shares outstanding for AbbVie (ABBV)

Number of shares outstanding as of June 2025 : 1,768,000,000

According to AbbVie's latest financial reports and stock price the company's current number of shares outstanding is 1,768,000,000. At the end of 2025 the company had 1,768,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for AbbVie from 2011 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20251.76 B0.16%
20241.76 B-0.04%
20231.76 B-0.18%
20221.76 B0.05%
20211.76 B0.18%
20201.76 B19.35%
20191.47 B0.01%
20181.47 B-7.12%
20171.59 B-0.02%
20161.59 B-1.08%
20151.60 B1.16%
20141.59 B0.25%
20131.58 B0.47%
20121.58 B-2.23%
20111.61 B

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Pfizer
PFE
5,675,000,000 220.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,031,000,000 14.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
897,989,151-49.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
538,000,000-69.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
1,246,000,000-29.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
146,100,000-91.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
2,038,500,000 15.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
3,100,000,000 75.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
99,700,000-94.36%๐Ÿ‡บ๐Ÿ‡ธ USA